Toll-like receptor (TLR)-1/2 triggering of multiple myeloma cells modulates their adhesion to bone marrow stromal cells and enhances bortezomib-induced apoptosis. [electronic resource]
Producer: 20150604Description: e96608 p. digitalISSN:- 1932-6203
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Bone Marrow Cells -- drug effects
- Boronic Acids -- pharmacology
- Bortezomib
- Cell Adhesion -- drug effects
- Cell Line, Tumor
- Humans
- Integrins -- immunology
- Lipopeptides -- pharmacology
- Multiple Myeloma -- drug therapy
- Pyrazines -- pharmacology
- Stromal Cells -- drug effects
- Toll-Like Receptor 1 -- agonists
- Toll-Like Receptor 2 -- agonists
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.